RJA
EXAS

Ross\Johnson & Associates’s Exact Sciences EXAS Stock Holding History

Ross\Johnson & Associates’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-250
Closed -$10.8K – 252
2025
Q1 		$10.8K Buy
+250
New +$12.7K 0.19% 51

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Ross\Johnson & Associates's EXAS Position: Q2 2025 in Review

Ross\Johnson & Associates sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 250 shares — an estimated $10.8K sold.

Ross\Johnson & Associates first reported a position in EXAS in Q1 2025 and held it in 1 quarter. The position peaked at $10.8K in Q1 2025. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Ross\Johnson & Associates reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Ross\Johnson & Associates sold 250 Exact Sciences shares in Q2 2025, an estimated $10.8K.
  • Ross\Johnson & Associates first reported a position in Exact Sciences in Q1 2025 and held it in 1 quarter.
  • Ross\Johnson & Associates's Exact Sciences position peaked at $10.8K in Q1 2025.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Ross\Johnson & Associates's 13F filing for Q2 2025, filed 15 Aug 2025.